malondialdehyde has been researched along with Lupus Erythematosus, Systemic in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (6.67) | 18.7374 |
1990's | 6 (13.33) | 18.2507 |
2000's | 10 (22.22) | 29.6817 |
2010's | 23 (51.11) | 24.3611 |
2020's | 3 (6.67) | 2.80 |
Authors | Studies |
---|---|
Chowdhury, MAZ; Das, A; Das, DC; Deb, SR; Fardous, Z; Hossain, MM; Hussain, MS; Jahan, I; Kabir, AKMH; Rahman, MM; Siddique, MAB | 1 |
Biswas, S; Dalal, V; Pathak, A; Paul, A; Ramani, S | 1 |
Accardi, G; Aiello, A; Candore, G; Carru, C; Caruso, C; Ciaccio, M; Gambino, CM; Gioia, BG; Guggino, G; Rizzo, S; Zinellu, A | 1 |
Bahrehmand, F; Baniamerian, H; Pourmotabbed, T; Rahimi, Z; Vaisi-Raygani, A | 1 |
Ansari, GAS; Khan, MF; Wang, G; Wang, J | 1 |
Bahrehmand, F; Kiani, A; Miri, A; Pourmotabbed, T; Rahimi, Z; Shakiba, E; Tanhapour, M; Vaisi-Raygani, A | 1 |
Buyon, JP; Clancy, RM; Grönwall, C; Gunnarsson, I; Hardt, U; Larsson, A; Petri, M; Silverman, GJ; Svenungsson, E | 1 |
Habazi, D; Han, J; Mohan, C; Saxena, R; Wu, T; Ye, Y; Zhang, T | 1 |
Ahmadi, R; Bahrehmand, F; Kiani, A; Pourmotabbed, T; Rahimi, Z; Tavilani, H; Vaisi-Raygani, A | 1 |
Ahmadi, R; Bahrehmand, F; Kiani, A; Pourmotabbed, T; Rahimi, Z; Tavilani, H; Vaisi-Raygani, A; Vaisi-Raygani, H | 1 |
Gheita, TA; Kenawy, SA | 1 |
Ardalan, M; Bahrehmand, F; Kiani, A; Pourmotabbed, T; Rahimi, Z; Shakiba, E; Tavilani, H; Vaisi-Raygani, A; Vaisi-Raygani, H | 1 |
Elvin, K; Engelbertsen, D; Fredrikson, GN; Gunnarsson, I; Gustafsson, JT; Jensen-Urstad, K; Nilsson, J; Svenungsson, E; Wigren, M | 1 |
Ghafoori, H; Moori, M; Sariri, R | 1 |
Fiskesund, R; Frostegård, AG; Frostegård, J; Golabkesh, Z; Gustafsson, T; Hafström, I; Jogestrand, T; Liu, A; Rahman, M; Sing, S | 1 |
Gonzalez, EB; Khan, MF; Petri, M; Pierangeli, SS; Wang, G; Willis, R | 1 |
Bahrehmand, F; Khazaei, M; Kiani, A; Nomani, H; Pourmotabbed, T; Rahimi, Z; Tanhapour, M; Tavilani, H; Vaisi-Raygani, A | 1 |
Janwityanuchit, S; Panomvana, D; Tewthanom, K; Totemchockchyakarn, K | 1 |
Dağli, N; Işik, A; Karaca, I; Koca, SS; Ozgen, M; Ustündağ, B; Yavuzkir, MF | 1 |
Bhatnagar, A; Kiran, R; Shah, D; Wanchu, A | 1 |
Ansari, GA; Khan, MF; Papalardo, E; Pierangeli, SS; Wang, G | 1 |
Aïfa, MS; Attia, H; Bahloul, Z; Ben Mansour, R; Elgaied, A; Fakhfakh, F; Haddouk, S; Lassoued, S; Marzouk, S; Masmoudi, H | 1 |
Bhatnagar, A; Shah, D; Wanchu, A | 1 |
Abdou, MS; El-Sorougy, IM; Fahim, AT; Gheita, TA; Hassan, SZ; Kenawy, SA | 1 |
Akhter, E; Burlingame, RW; Grönwall, C; Oh, C; Petri, M; Silverman, GJ | 1 |
Lima, DS; Lima, ES; Netto, Rde C; Pérez, LC; Pérez, YG | 1 |
Bhatnagar, A; Sah, S; Shah, D; Wanchu, A; Wu, MX | 1 |
Firoze Khan, M; Li, H; Wang, G | 1 |
Akcay, F; Bakan, N; Gul, M; Sari, RA; Taysi, S | 1 |
Bae, SC; Kim, SJ; Sung, MK | 1 |
Kurien, BT; Scofield, RH | 1 |
Benzie, IF; Griffith, JF; Lee, KK; Lee, VW; Leung, VY; Li, EK; Lim, PL; Tam, LS; Thomas, GN; Tomlinson, B; Whitney, B | 1 |
Damoiseaux, J; Jeyasekharan, AD; Tervaert, JW; Theunissen, R | 1 |
Butkene, B; Iasiulevichute, L; Keturkene, A; Redaĭtene, E; Valiukene, K; Vipartene, D | 1 |
Dorsch, CA; Meyerhoff, J | 1 |
Craig, WY; Nelson, CP; Poulin, SE; Ritchie, RF | 1 |
Albrecht-Nebe, H; Eggert, W; Grune, T; Michel, P | 1 |
Albrecht-Nebe, H; Eggert, W; Esterbauer, H; Grune, T; Michel, P; Siems, WG; Sitte, N | 1 |
Hughes, GR; Khamashta, MA; Romero, FI | 1 |
de Faire, U; Frostegård, J; Hamsten, A; Heimbürger, M; Jensen-Urstad, K; Silveira, A; Svenungsson, E; Witztum, JL | 1 |
Bedö, Z; Chuchalin, AG; Csípö, I; Kormos, T; Lebedin, JS; Shmushkovich, BJ; Sipka, S; Szegedi, G | 1 |
Avenarius, HJ; Deicher, H; Horn, A | 1 |
Agisheva, KN; Salikhov, IG | 1 |
Kudriavtseva, GV; Makarov, SA; Shishkin, VI | 1 |
Jin, ZJ; Kurata, Y; Mizutani, H; Tarui, S; Tomiyama, Y; Tsubakio, T; Yonezawa, T | 1 |
2 review(s) available for malondialdehyde and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Oxidative Stress in Autoimmune Diseases: An Under Dealt Malice.
Topics: Arthritis, Rheumatoid; Autoantibodies; Autoimmunity; Diabetes Mellitus, Type 1; Gene Expression; Genetic Predisposition to Disease; HLA Antigens; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Malondialdehyde; Multiple Sclerosis; Oxidative Stress; Reactive Oxygen Species; Receptors, Fc | 2020 |
Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis.
Topics: Antiphospholipid Syndrome; Arteriosclerosis; Autoantibodies; Humans; Lipoprotein(a); Lipoproteins, LDL; Lupus Erythematosus, Systemic; Malondialdehyde; Oxidation-Reduction | 2000 |
2 trial(s) available for malondialdehyde and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Altered redox state and apoptosis in the pathogenesis of systemic lupus erythematosus.
Topics: Adult; Apoptosis; Caspase 3; Female; Glutathione; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Lymphocytes; Male; Malondialdehyde; Oxidative Stress; Reactive Oxygen Species; Severity of Illness Index | 2013 |
Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
Topics: Allantoin; Antioxidants; Ascorbic Acid; Biomarkers; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Health Status; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Severity of Illness Index; Vasodilation; Vitamin E | 2005 |
41 other study(ies) available for malondialdehyde and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Alterations of serum trace elements and other biochemical parameters are correlated with the pathogenesis of systemic lupus erythematosus: A preliminary study on Bangladeshi population.
Topics: Ascorbic Acid; Bangladesh; C-Reactive Protein; Case-Control Studies; Humans; Lupus Erythematosus, Systemic; Malondialdehyde; Trace Elements; Vitamins | 2021 |
Uncoupling Protein 2 as genetic risk factor for systemic lupus erythematosus: association with malondialdehyde levels and intima media thickness.
Topics: Carotid Intima-Media Thickness; Humans; Lupus Erythematosus, Systemic; Malondialdehyde; Risk Factors; Uncoupling Protein 2 | 2020 |
Angiotensin type 1 receptor A1166C polymorphism and systemic lupus erythematosus: correlation with cellular immunity and oxidative stress markers.
Topics: Adolescent; Adult; Aged; Biomarkers; Case-Control Studies; Female; Genotype; Humans; Immunity, Cellular; Iran; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Neopterin; Oxidative Stress; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 1; Triglycerides; Young Adult | 2017 |
Autoimmune potential of perchloroethylene: Role of lipid-derived aldehydes.
Topics: Animals; Antibodies; Autoimmunity; Cell Proliferation; Disease Models, Animal; Female; Glutathione; Interleukin-17; Lipids; Lupus Erythematosus, Systemic; Malondialdehyde; Mice; Protein Binding; Scleroderma, Systemic; Solvents; Spleen; Superoxide Dismutase; Tetrachloroethylene; Th17 Cells | 2017 |
Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
Topics: Adult; Alleles; Apolipoprotein E4; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Iran; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Neopterin; Polymorphism, Single Nucleotide; Young Adult | 2018 |
Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
Topics: Adult; Autoantibodies; Autoimmunity; Biomarkers; Cohort Studies; Cross-Sectional Studies; Female; Humans; Immunoglobulin G; Immunoglobulin M; Inflammation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Malondialdehyde; Middle Aged; Prognosis; Severity of Illness Index | 2018 |
Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE.
Topics: Autoantibodies; Case-Control Studies; Complement C3; Complement C4; DNA; Humans; Immunoglobulin G; Immunoglobulin M; Linoleic Acids; Linoleic Acids, Conjugated; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Malondialdehyde; Phospholipid Ethers; Severity of Illness Index | 2019 |
Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus.
Topics: Adolescent; Adult; Aged; Aryldialkylphosphatase; Case-Control Studies; Female; Genotype; Humans; Lipids; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Polymorphism, Genetic | 2013 |
Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Topics: Adolescent; Adult; Aged; Aryldialkylphosphatase; Biomarkers; Butyrylcholinesterase; Case-Control Studies; Cholesterol, LDL; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Iran; Lipid Peroxidation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Neopterin; Oxidative Stress; Phenotype; Risk Assessment; Risk Factors; Severity of Illness Index; Young Adult | 2014 |
Measurement of malondialdehyde, glutathione, and glutathione peroxidase in SLE patients.
Topics: Biomarkers; Glutathione; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Malondialdehyde; Oxidative Stress | 2014 |
Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
Topics: Adult; Alleles; Biomarkers; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Neopterin; Oxidative Stress; Polymerase Chain Reaction; Polymorphism, Single Nucleotide | 2015 |
Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
Topics: Adult; Apolipoprotein B-100; Autoantibodies; Cardiovascular Diseases; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Immunoglobulin M; Logistic Models; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Risk Factors | 2015 |
Nonenzymatic antioxidants in saliva of patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Antioxidants; Biomarkers; Case-Control Studies; Female; Glutathione; Humans; Lupus Erythematosus, Systemic; Malondialdehyde; Middle Aged; Oxidative Stress; Saliva; Uric Acid; Young Adult | 2016 |
IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
Topics: Adult; Apoptosis; Atherosclerosis; B-Lymphocytes; Biomarkers; Carotid Intima-Media Thickness; CD3 Complex; Cells, Cultured; Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Female; Humans; Immunoglobulin M; Jurkat Cells; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Phagocytosis; Phosphorylcholine; Plaque, Atherosclerotic; T-Lymphocytes; Ultrasonography | 2016 |
Significance of Lipid-Derived Reactive Aldehyde-Specific Immune Complexes in Systemic Lupus Erythematosus.
Topics: Adult; Aged; Aldehydes; Antigen-Antibody Complex; Blood Proteins; Case-Control Studies; Catalase; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-17; Lipid Peroxidation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Severity of Illness Index; Superoxide Dismutase | 2016 |
Association between the cytotoxic T-lymphocyte antigen-4 mutations and the susceptibility to systemic lupus erythematosus; Contribution markers of inflammation and oxidative stress.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Case-Control Studies; CTLA-4 Antigen; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Inflammation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Polymorphism, Single Nucleotide; Young Adult | 2016 |
Correlation of lipid peroxidation and glutathione levels with severity of systemic lupus erythematosus: a pilot study from single center.
Topics: Adult; Female; Glutathione; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Severity of Illness Index | 2008 |
Insulin resistance is related with oxidative stress in systemic lupus erythematosus.
Topics: Adolescent; Adult; Atherosclerosis; Biomarkers; Case-Control Studies; Comorbidity; Cross-Sectional Studies; Female; Homeostasis; Humans; Insulin; Insulin Resistance; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Risk Factors; Young Adult | 2009 |
Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity.
Topics: Adult; Catalase; Cell Extracts; Cells, Cultured; Disease Progression; Erythrocytes; Female; Glutathione; Humans; Interferon-gamma; Interleukin-12; Lipid Peroxidation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Oxidative Stress; Superoxide Dismutase; Th1 Cells | 2010 |
Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.
Topics: Adult; Aged; Biomarkers; Disease Progression; Female; Health Status; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Severity of Illness Index; Superoxide Dismutase; Tyrosine; Young Adult | 2010 |
Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies.
Topics: Analysis of Variance; Autoantibodies; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Humans; Lupus Erythematosus, Systemic; Malondialdehyde; Proteins; Superoxide Dismutase | 2010 |
Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Biomarkers; Case-Control Studies; Catalase; Chemokines; Enzyme-Linked Immunosorbent Assay; Female; Glutathione; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Oxidative Stress; Reactive Oxygen Species; Regression Analysis; Superoxide Dismutase | 2011 |
Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity.
Topics: Adult; Arthritis, Rheumatoid; Biomarkers; Female; Health Status; Humans; Joints; Lipid Peroxidation; Lupus Erythematosus, Systemic; Malondialdehyde; Middle Aged; Oxidative Stress; Oxidoreductases; Severity of Illness Index; Young Adult | 2011 |
IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Antigens; Apoptosis; Autoantibodies; Cardiovascular Diseases; Female; Humans; Kidney Diseases; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Phosphorylcholine | 2012 |
Malondialdehyde and sulfhydryl groups as biomarkers of oxidative stress in patients with systemic lupus erythematosus.
Topics: Adult; Biomarkers; Case-Control Studies; Female; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Oxidative Stress; Sulfhydryl Compounds | 2012 |
Differential oxidative modification of proteins in MRL+/+ and MRL/lpr mice: Increased formation of lipid peroxidation-derived aldehyde-protein adducts may contribute to accelerated onset of autoimmune response.
Topics: Aldehydes; Animals; Autoantibodies; Autoimmunity; Enzyme-Linked Immunosorbent Assay; Female; Lipid Peroxidation; Lupus Erythematosus, Systemic; Malondialdehyde; Mice; Mice, Inbred MRL lpr; Oxidation-Reduction; Oxidative Stress; Proteins | 2012 |
Serum oxidant/antioxidant status of patients with systemic lupus erythematosus.
Topics: Adult; Antioxidants; Biomarkers; Case-Control Studies; Catalase; Ceruloplasmin; Female; Glutathione Peroxidase; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Severity of Illness Index; Superoxide Dismutase; Transferrin | 2002 |
Impaired antioxidant status and decreased dietary intake of antioxidants in patients with systemic lupus erythematosus.
Topics: Adult; alpha-Tocopherol; Antioxidants; Diet; Diet Surveys; Disability Evaluation; Female; Glutathione Peroxidase; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Severity of Illness Index; Superoxide Dismutase; Surveys and Questionnaires | 2002 |
Free radical mediated peroxidative damage in systemic lupus erythematosus.
Topics: Autoantibodies; Enzyme-Linked Immunosorbent Assay; Free Radicals; Humans; Lipid Peroxidation; Lipid Peroxides; Lupus Erythematosus, Systemic; Malondialdehyde; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2003 |
Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Arteriosclerosis; Autoantibodies; Copper; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Immunoglobulin M; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Malondialdehyde; Oxidation-Reduction; Statistics, Nonparametric | 2005 |
[Pro- and antioxidant blood system in patients with rheumatoid arthritis and systemic lupus erythematosus].
Topics: Antioxidants; Arthritis, Rheumatoid; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Prevalence; Severity of Illness Index; Spectrophotometry, Atomic; Superoxide Dismutase | 2006 |
Mechanisms of abnormal platelet aggregation in systemic lupus erythematosus.
Topics: Blood Platelet Disorders; Blood Platelets; Collagen; Deoxyribonucleases; DNA; Epinephrine; Female; Humans; Lupus Erythematosus, Systemic; Malondialdehyde; Platelet Aggregation; Serotonin | 1982 |
ELISA of IgG antibody to oxidized low-density lipoprotein: effects of blocking buffer and method of data expression.
Topics: Adolescent; Adult; Aged; Antigens; Autoantibodies; Buffers; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Lipid Peroxidation; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Malondialdehyde; Middle Aged; Oxidation-Reduction; Sensitivity and Specificity; Serum Albumin; Thiobarbituric Acid Reactive Substances | 1994 |
Increased lipid peroxidation in children with autoimmune diseases.
Topics: Adolescent; Adult; Aldehydes; Autoimmunity; Child; Female; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Scleroderma, Localized | 1997 |
Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases.
Topics: Adolescent; Aldehydes; Blood Proteins; Blotting, Western; Child; Child, Preschool; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Malondialdehyde | 1997 |
Risk factors for cardiovascular disease in systemic lupus erythematosus.
Topics: Autoantibodies; Biomarkers; Cardiovascular Diseases; Carotid Artery, Common; Case-Control Studies; Cohort Studies; Comorbidity; Epitopes; Female; Humans; Lipids; Lipoproteins; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Malondialdehyde; Middle Aged; Osteoporosis; Prevalence; Risk Factors; Sweden; Ultrasonography | 2001 |
Leukocytosis induced by plasma exchange.
Topics: Humans; Leukocyte Count; Leukocytosis; Luminescent Measurements; Lupus Erythematosus, Systemic; Malondialdehyde; Myasthenia Gravis; Neutrophils; Plasma Exchange | 1991 |
[Thrombocyte function and thrombocyte-associated immunoglobulins in patients with systemic lupus erythematosus and chronic polyarthritis].
Topics: Arthritis, Rheumatoid; Autoantibodies; Blood Platelets; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Malondialdehyde; Platelet Aggregation; Platelet Count; Platelet Function Tests; Serotonin | 1990 |
[Lipid peroxidation and state of antioxidant system in patients with systemic lupus erythematosus].
Topics: Adolescent; Adult; Antioxidants; Fatty Acids, Nonesterified; Female; Humans; Lipid Peroxidation; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Vitamin E | 1990 |
[Prostaglandins in the pathogenesis of various systemic diseases of the connective tissue].
Topics: Adult; Arthritis, Rheumatoid; Connective Tissue Diseases; Female; Humans; Lupus Erythematosus, Systemic; Male; Malondialdehyde; Middle Aged; Prostaglandins; Scleroderma, Systemic | 1987 |
[The clinical significance of PAIgG in various disorders--a study on platelet lifespan using malondialdehyde method].
Topics: Anemia, Aplastic; Blood Platelets; Cell Survival; Humans; Immunoglobulin G; Liver Cirrhosis; Lupus Erythematosus, Systemic; Malonates; Malondialdehyde; Purpura, Thrombocytopenic | 1986 |